Default company panoramic image
Logo

Bali Pharma

Prescription drug products to increase cancer patient survival and quality of life by reducing chemotherapy and radiation side effects

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location New York City, NY, USA
  • Currency USD
  • Founded January 2010
  • Employees 4
  • Website balimed.com

Company Summary

Bali Pharma develops & commercializes pharmaceuticals to increase cancer patient survival and quality of life by reducing cancer therapy-induced toxicities which increases safety and effectiveness of the primary treatment. Bali re-purposes patented compounds as FDA-approved oncology drugs for toxic damage to nerve, intestinal and immune cells resulting in treatment discontinuation, patient distress, and FDA approval delays for newer therapies.

Team

  • Default avatar
    Zeil Rosenberg, MD
    CEO and Founder
    Unconfirmed

    Experienced physician executive with > 20 years of senior management experience. 8 years leading high growth worldwide business unit at Becton Dickinson bringing 4 platforms through FDA; CEO of small cap biotech company; BA ecomomics from Stanford; MD from UCSF; Residency at Cornell; MPH and on faculty now at Columbia. Entrepreneurial and well known for his work on vaccine technology.